awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q41333886-02016E35-299F-424C-9AC6-79E27001A04D
Q41333886-02016E35-299F-424C-9AC6-79E27001A04D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41333886-02016E35-299F-424C-9AC6-79E27001A04D
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
P2860
Q41333886-02016E35-299F-424C-9AC6-79E27001A04D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41333886-02016E35-299F-424C-9AC6-79E27001A04D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
327dd7b46cb827a5881a7a6f743ecc840f8c01ef
P2860
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer